NASDAQ:OLK Olink Holding AB (publ) (OLK) Stock Price, News & Analysis $26.08 0.00 (0.00%) (As of 08/20/2024) Add Compare Share Share Today's Range$26.08▼$26.0850-Day Range$25.55▼$26.0852-Week Range$14.10▼$26.09Volume1,000 shsAverage Volume633,228 shsMarket Capitalization$3.24 billionP/E RatioN/ADividend YieldN/APrice Target$26.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends Get Olink Holding AB (publ) alerts: Email Address Olink Holding AB (publ) MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside0.3% Downside$26.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.19) to $0.02 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.01 out of 5 starsMedical Sector908th out of 910 stocksAnalytical Instruments Industry26th out of 26 stocks 1.0 Analyst's Opinion Consensus RatingOlink Holding AB (publ) has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageOlink Holding AB (publ) has received no research coverage in the past 90 days.Read more about Olink Holding AB (publ)'s stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for OLK. Previous Next 0.0 Dividend Strength Dividend YieldOlink Holding AB (publ) does not currently pay a dividend.Dividend GrowthOlink Holding AB (publ) does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OLK. Previous Next 1.1 News and Social Media Coverage Search Interest2 people have searched for OLK on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Olink Holding AB (publ) to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Olink Holding AB (publ) insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.20% of the stock of Olink Holding AB (publ) is held by insiders.Percentage Held by InstitutionsOnly 30.19% of the stock of Olink Holding AB (publ) is held by institutions.Read more about Olink Holding AB (publ)'s insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Olink Holding AB (publ) are expected to grow in the coming year, from ($0.19) to $0.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Olink Holding AB (publ) is -96.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Olink Holding AB (publ) is -96.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOlink Holding AB (publ) has a P/B Ratio of 6.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. About Olink Holding AB (publ) Stock (NASDAQ:OLK)Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.Read More OLK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OLK Stock News HeadlinesAugust 8, 2024 | au.finance.yahoo.comOlink Holding AB (6XA.SG)July 11, 2024 | globenewswire.comNotice to attend the Extra General Meeting of Olink Holding AB (publ)September 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.July 8, 2024 | globenewswire.comOlink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo FisherJuly 8, 2024 | reuters.comUK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink dealJuly 8, 2024 | reuters.comUK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink dealJuly 5, 2024 | globenewswire.comReport from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024July 3, 2024 | globenewswire.comOlink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker DiscoverySeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.June 11, 2024 | globenewswire.comNotice to attend the Extra General Meeting of Olink Holding AB (publ)June 6, 2024 | globenewswire.comOlink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute ConfidenceMay 16, 2024 | markets.businessinsider.comBalanced Outlook: Holding Olink Amidst Growth Potential and Regulatory UncertaintiesMay 15, 2024 | markets.businessinsider.comHold Rating Maintained for Olink Holdings Amid Acquisition Uncertainty and Mixed Financial PerformanceMay 13, 2024 | globenewswire.comOlink reports first quarter 2024 financial resultsMay 10, 2024 | reuters.comUK's CMA kicks off probe into Thermo Fisher-Olink dealMay 3, 2024 | businesswire.comSampled Named One of the First Olink® Certified Service ProvidersApril 19, 2024 | globenewswire.comReport from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024April 2, 2024 | finance.yahoo.comOlink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of DiseaseSee More Headlines Receive OLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Olink Holding AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:OLK CUSIPN/A CIK1835539 Webwww.olink.com Phone46 (0) 18 444 39 70FaxN/AEmployees420Year FoundedN/APrice Target and Rating Average Stock Price Target$26.00 High Stock Price Target$26.00 Low Stock Price Target$26.00 Potential Upside/Downside-0.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-31,600,000.00 Net Margins-19.72% Pretax Margin-24.84% Return on Equity-7.07% Return on Assets-6.05% Debt Debt-to-Equity RatioN/A Current Ratio5.60 Quick Ratio3.91 Sales & Book Value Annual Sales$170.89 million Price / Sales18.98 Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book6.46Miscellaneous Outstanding Shares124,343,000Free Float117,877,000Market Cap$3.24 billion OptionableOptionable Beta0.52 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Jon Heimer (Age 57)CEO & Director Comp: $889.39kMr. Carl Raimond (Age 53)President Mr. Oskar Hjelm (Age 39)Chief Financial Officer Ms. Anna Marsell (Age 46)Chief Operating Officer Mr. Jan Medina CFAVice President of Investor Relations & Capital MarketsMs. Linda Ramirez-Eaves Esq. (Age 52)General Counsel Andrea PranderCorporate Communications ManagerMr. Elias BerglundChief People OfficerMr. Rickard El Tarzi (Age 38)Chief Strategy Officer Mr. Bruno RossiChief Commercial OfficerMore ExecutivesKey CompetitorsGenMark DiagnosticsNASDAQ:GNMKLuminexNASDAQ:LMNXMeridian BioscienceNASDAQ:VIVONatus MedicalNASDAQ:NTUSVarex ImagingNASDAQ:VREXView All CompetitorsInstitutional OwnershipWater Island Capital LLCSold 202,609 shares on 8/16/2024Ownership: 1.173%Millennium Management LLCSold 849,103 shares on 8/15/2024Ownership: 0.752%Absolute Gestao de Investimentos Ltda.Bought 627 shares on 8/15/2024Ownership: 0.440%DeepCurrents Investment Group LLCBought 63,041 shares on 8/15/2024Ownership: 0.051%Marshall Wace LLPBought 7,520 shares on 8/14/2024Ownership: 0.449%View All Institutional Transactions OLK Stock Analysis - Frequently Asked Questions How have OLK shares performed this year? Olink Holding AB (publ)'s stock was trading at $25.15 on January 1st, 2024. Since then, OLK shares have increased by 3.7% and is now trading at $26.08. View the best growth stocks for 2024 here. How were Olink Holding AB (publ)'s earnings last quarter? Olink Holding AB (publ) (NASDAQ:OLK) released its quarterly earnings data on Monday, May, 13th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The business had revenue of $28.75 million for the quarter, compared to the consensus estimate of $31.29 million. Olink Holding AB (publ) had a negative net margin of 19.72% and a negative trailing twelve-month return on equity of 7.07%. When did Olink Holding AB (publ) IPO? Olink Holding AB (publ) (OLK) raised $301 million in an initial public offering on Thursday, March 25th 2021. The company issued 17,700,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley and SVB Leerink served as the underwriters for the IPO and BTIG was co-manager. Who are Olink Holding AB (publ)'s major shareholders? Top institutional shareholders of Olink Holding AB (publ) include Alpine Associates Management Inc. (2.09%), Magnetar Financial LLC (1.64%), Water Island Capital LLC (1.17%) and Millennium Management LLC (0.75%). How do I buy shares of Olink Holding AB (publ)? Shares of OLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OLK) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olink Holding AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Olink Holding AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.